TP53 and breast cancer: Our findings predict that oncogenic MDM4 inhibits wt p53 functions during PC pathogenesis, as consistent with previous reports in melanoma [23] and breast cancers [19], where oncogenic activity of MDM4 has also been identified to suppress wt p53 functions [56].